Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

British Drug Regulator Recalls Wockhardt Ltd Medicines-Reuters


Thursday, 11 Jul 2013 09:59am EDT 

Reuters reported that Britain's MHRA drug regulator has halted the sale of 16 medicines made by Wockhardt after it identified manufacturing deficiencies at the Indian group's Waluj factory. Though the Medicines and Healthcare products Regulatory Agency said there is no evidence that the products are defective and that patients who already have the medicines do not need to return them, pharmacies, dispensing clinics and wholesalers have been asked to stop selling them. 

Company Quote

585.5
16.1 +2.83%
1:02am EDT